Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment

Lionel Perrier, Nicola Cautela, Magali Morelle (), Nathalie Havet (), FRançoise Ducimetière, Antoine Lurkin, Jean-Yves Blay, Pierre Biron, Dominique Ranchère-Vince, Anne-Valérie Decouvelaere, Philippe Thiesse, Christophe Bergeron, François Gilly, Guy de Laroche, Dominic Cellier, Mathieu Laramas, Thierry Philip and Isabelle Ray-Coquar
Additional contact information
Magali Morelle: GATE, University of Lyon, CNRS, ENS-LSH, Centre Léon Bérard, France

No 822, Working Papers from Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon

Abstract: Background: The impact of compliance to clinical practice guidelines (CPG) on outcomes and/or costs of care has not been completely clarified. Objective: To estimate relationships between medical expenditures and compliance to CPG for initial sarcoma treatment. Research design: Selected cohorts of patients diagnosed with sarcoma in 2005 and 2006, and treated at the University hospital and/or the cancer centre of the Rhône-Alpes region, France (n=90). Main outcome measurements were: patient characteristics, compliance with CPG, health outcomes, and costs. Data were mainly extracted from patient records. The logarithm of treatment costs was modelled using linear and Tobit regressions. Results: Rates of compliance with CPG were 86%, 66%, 88%, 89%, and 95% for initial diagnosis, primary surgical excision, wide surgical excision, chemotherapy, and radiotherapy, respectively. Total average costs reached €24,439, with €1,784, €11,225, €10,360, and €1,016 for diagnosis, surgery (primary and wide surgical excisions), chemotherapy, and radiotherapy, respectively. Compliance of diagnosis with CPG decreased the cost of diagnosis, whereas compliance of primary surgical excision increased the cost of chemotherapy. Compliance of chemotherapy with CPG decreased the cost of radiotherapy. Conclusion: Since chemotherapy is one of the major cost drivers, these results support that compliance with guidelines increases medical care expenditures in short term.

Keywords: Oncology; Sarcoma; Cost; Clinical guidelines; Efficacy; Medical Practices (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
Pages: 38 pages
Date: 2008
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
ftp://ftp.gate.cnrs.fr/RePEc/2008/0822.pdf (application/pdf)

Related works:
Working Paper: Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment (2008)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gat:wpaper:0822

Access Statistics for this paper

More papers in Working Papers from Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon Contact information at EDIRC.
Bibliographic data for series maintained by Nelly Wirth ( this e-mail address is bad, please contact ).